From the Division of Endocrinology, Department of Medicine, University of Arizona College of Medicine, Tucson.
Hypertension. 2020 Dec;76(6):1787-1799. doi: 10.1161/HYPERTENSIONAHA.120.16118. Epub 2020 Oct 5.
Damage-associated molecular patterns, such as HMGB1 (high mobility group box 1), play a well-recognized role in the development of pulmonary arterial hypertension (PAH), a progressive fatal disease of the pulmonary vasculature. However, the contribution of the particular type of vascular cells, type of cell death, or the form of released HMGB1 in PAH remains unclear. Moreover, although male patients with PAH show a higher level of circulating HMGB1, its involvement in the severe PAH phenotype reported in males is unknown. In this study, we aimed to investigate the sources and active forms of HMGB1 released from damaged vascular cells and their contribution to the progressive type of PAH in males. Our results showed that HMGB1 is released by either pulmonary artery human endothelial cells or human pulmonary artery smooth muscle cells that underwent necrotic cell death, although only human pulmonary artery smooth muscle cells produce HMGB1 during apoptosis. Moreover, only human pulmonary artery smooth muscle cell death induced a release of dimeric HMGB1, found to be mitochondrial reactive oxygen species dependent, and TLR4 (toll-like receptor 4) activation. The modified Sugen/Hypoxia rat model replicates the human sexual dimorphism in PAH severity (right ventricle systolic pressure in males versus females 54.7±2.3 versus 44.6±2 mm Hg). By using this model, we confirmed that necroptosis and necrosis are the primary sources of circulating HMGB1 in the male rats, although only necrosis increased circulation of HMGB1 dimers. Attenuation of necrosis but not apoptosis or necroptosis prevented TLR4 activation in males and blunted the sex differences in PAH severity. We conclude that necrosis, through the release of HMGB1 dimers, predisposes males to a progressive form of PAH.
损伤相关分子模式,如高迁移率族蛋白 B1(HMGB1),在肺动脉高压(PAH)的发生发展中起着公认的作用,PAH 是一种进行性致命的肺血管疾病。然而,特定类型的血管细胞、细胞死亡类型或释放的 HMGB1 形式在 PAH 中的作用仍不清楚。此外,尽管男性 PAH 患者的循环 HMGB1 水平较高,但它在男性报道的严重 PAH 表型中的作用尚不清楚。在这项研究中,我们旨在研究受损血管细胞释放的 HMGB1 的来源和活性形式及其对男性进行性 PAH 的贡献。我们的研究结果表明,HMGB1 是由坏死性细胞死亡的人肺动脉内皮细胞或人肺动脉平滑肌细胞释放的,尽管只有人肺动脉平滑肌细胞在凋亡过程中产生 HMGB1。此外,只有人肺动脉平滑肌细胞死亡诱导二聚 HMGB1 的释放,发现这依赖于线粒体活性氧物质和 TLR4( toll-like receptor 4)的激活。苏根/低氧大鼠模型复制了 PAH 严重程度的人类性别二态性(雄性右心室收缩压为 54.7±2.3mmHg,而雌性为 44.6±2mmHg)。通过使用该模型,我们证实坏死性细胞死亡和坏死是雄性大鼠循环 HMGB1 的主要来源,尽管只有坏死增加了循环 HMGB1 二聚体。在雄性大鼠中,抑制坏死但不抑制细胞凋亡或坏死性细胞死亡可预防 TLR4 激活,并减轻 PAH 严重程度的性别差异。我们的结论是,坏死通过释放 HMGB1 二聚体,使男性易患进行性 PAH。